Status: Recruiting
The KN510713 Study in Combination With mFOLFIRINOX
This study is designed to evaluate the safety and efficacy of KN510713 in combination with mFOLFIRINOX in patients with locally advanced or metastatic pancreatic cancer. The study will be conducted in two parts: Part 1 (Dose-finding) and Part 2 (Dose expansion).
Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 19-75Biological sex: AllType: InterventionalSponsor: New Cancer Cure-Bio Co.,Ltd.Updated: Apr 13, 2026Locations: 1
Eligibility criteria
Adult male and female subjects aged 19 to 75 years at the time of providing writ... [+7]
History of any malignancy other than pancreatic cancer within 5 years prior to s... [+16]